A Phase 3 study of the long-term safety of a triple combination therapy of VX-445, tezacaftor and ivacaftor in people with cystic fibrosis aged 12 and older. Efficacy of domiciliary non-invasive ventilation in patients with respiratory failure due to non-CF bronchiectasis, Study contact information Name: Dr Carole RidgeEmail:C.Ridge@rbht.nhs.uk, Study His practice is broad and covers a variety of congenital disorders including connective . 12,185 were here. Name:Professor Toby MaherEmail:T.Maher@rbht.nhs.uk, Study Study Dr Elizabeth Renzoni. Study Name:Ms Ana DoceHurtadoEmail:A.HurtadoDoce@rbht.nhs.uk, Principal investigator A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH, Study contact informationName: Joy PinguelEmail: a.pinguel@rbht.nhs.uk, Study This provider currently accepts 50 insurance plans including Medicare and Medicaid. A pragmatic approach to the investigation of stable chest pain: a UK, multi-centre, randomised trial to improve patient experience, outcomes and NHS cost efficiency, Study contact information Name: Cristopher ShortEmail: C.Short@rbht.nhs.uk, Study Royal Brompton Hospital Contact: 020 7352 8121 ext 84133/ rbh-tr.thoraciccns-rbh@nhs.net Harefield Hospital Contact: 01895 828989/ rbh-tr.harefieldlungcns@nhs.net Administrative team Royal Brompton Hospital cancer team Maura Gallagher, cancer MDT co-ordinator Contact: 020 7352 8121 (ext 4303) Harefield Hospital cancer team A Surgical Site Infection Risk Prediction Tool to Enable Targeted Infection Prevention Strategies in Adult Cardiac Surgery. Name: Dr Francesca ConwayEmail:f.conway@rbht.nhs.uk, Study Study contact informationName:Sara SalmiEmail:S.Salmi@rbht.nhs.uk, Study contact informationName:Dr Benjamin HunterEmail:B.Hunter@rbht.nhs.uk, Study contact informationName:Melissa RochonEmail:M.Rochon@rbht.nhs.uk. Study contact information Name:Dr Amanda NatanekEmail:A.Natanek@rbht.nhs.uk. The London COPD cohort respiratory syncytial virus (RSV) study, Study contact information Does a pedometer-based walking programme affect exercise capacity and quality of life in sedentary adults with congenital heart disease? The HarEfield Acute MyocaRdial InfarcTion Cohort, Study contact informationName:Laura BarkerEmail:L.Barker2@rbht.nhs.uk, Study Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes, Study contact information Improving Primary Ciliary Dyskinesia diagnosis using artificial intelligence, Study contact information Find out more. Study contact information Dr Michael Loebinger, Study 44 Boulevard Becquart Castelbon, Voiron, Auvergne-Rhne-Alpes 38500 +33 4 76 65 99 60 . An observational study of neurodevelopmental outcome after cardiac arrest in children admitted to paediatric intensive care, Study contact information A Pan-European Multi-Centre Observational Study To Determine The Natural History Of Patients With Alpha-1 Antitrypsin Deficiency And The Impact Of Augmentation Therapy, Study contact information Name:Debra DempsterEmail:D.Dempster@rbht.nhs.uk, Study 2 Division of Anaesthetics, Pain Medicine, and Intensive Care, Department of Surgery and Cancer, Imperial College London, London, United Kingdom. See details of ourperformance for all clinical trials reported to the NIHR, for the Initiation and Delivery of studies in the period from 1 October 2020 to 31 March 2021. Project Fizzyo: Remote monitoring and gaming technology for improving physiotherapy prescription, adherence and prediction of clinical outcomes in children with cystic fibrosis. Study Name:Professor Martin CowieEmail:m.cowie@rbht.nhs.uk, Study Studying the microbiome of the lung in patients treated with endobronchial lung volume reduction coils for emphysema, Study contact information Study contact information Name:Darshan BrahmbhattEmail:d.brahmbhatt@rbht.nhs.uk, Study Professor Susanna Price & Dr Vasileios Panoulas, Study Study contact information Study contact informationName: Sally MeahEmail:sally.meah@imperial.ac.uk, Study Advanced echocardiography in critical care, Study contact information Name:Zohya KhaliqueEmail:Z.Khalique@rbht.nhs.uk, Principal investigator Study contact information This study aims to provide a contemporary, population-level assessment of the true clinical burden of myocarditis and how this may have changed over the last 20 years. Study contact information Prevalence of Pompes disease amongst patients with unexplained respiratory muscle weakness or respiratory failure, Study contact information Professor Michael Polkey, Study Study Professor Eric Lim, Study He is currently licensed to practice medicine in California. Name:Dr Anna ReedEmail:A.Reed@rbht.nhs.uk, Study Study Study contact informationName:Deirdre FlanneryEmail:D.Flannery@rbht.nhs.uk, Study MrAndreas Hoschtitzky. Name:Ms Nicky MurrayEmail:N.Murray@rbht.nhs.uk. DARS-NIC-144568-D7G6V, Study contact informationName:Amrit LotaEmail:A.Lota@rbht.nhs.uk. We provide private. Name:Aarif EifanEmail:A.Eifan@rbht.nhs.uk, Study Find Providers by Specialty Find Providers by Procedure. Study contact informationName:Paula RogersEmail:p.rogers@rbht.nhs.uk, Study Assessing mitochondrial bioenergetics in coronary heart disease; correlating cardiac magnetic resonance with the molecular processes that underpin myocardial dysfunction and left ventricular reverse remodelling. Name:Sally MeahEmail:S.Meah@rbht.nhs.uk, Study PRISM: Molecular phenotyping of participants with severe asthma to determine response to biologic therapies and stability, Study Study An open-label safety extension study to a multicenter study of liposomal amikacin for inhalation (LAI) in adult patients with non-Tuberculous Mycobacterial (NTM) lung infections caused by Mycobacterium avium complex (MAC) that are refractory to treatment, Study Study Name:Cai SimEmail:c.sim@rbht.nhs.uk, Principal investigator A Phase 3, open label, rollover study to evaluate the safety and efficacy of long term treatment with VX 661 in combination with Ivacaftor in subjects aged 12 years and older with Cystic Fibrosis , homozygous or heterozygous for the F508del CFTR mutation, Study contact information Multiple Breath Washout in paediatric chronic airways disease: Building a clinimetrics dataset, Study contact information Name:Dr Brijesh PatelEmail:B.Patel4@rbht.nhs.uk. The Feasibility of Continuous Bronchoscopy During Exercise in Healthy Adults in Assessing Large Airways Collapse, Study contact informationName: Alexandros MitropoulosEmail:A.Mitropoulos@rbht.nhs.uk, Study Perspectives On Screening and early Treatment for Pulmonary Fibrosis: a qualitative study, Study contact informationName: Dr Elizabeth RenzoniEmail: e.renzoni@rbht.nhs.uk. Study Aveir Dual-Chamber Leadless i2i IDE Study, Study contact information Study Study contact informationName:Lyn PaulEmail:l.paul@rbht.nhs.uk. Name: Jessie MatthewsEmail: j.matthews@rbht.nhs.uk, Study Study Pre-school Wheeze: Predicting Progression to School Aged Asthma, Study contact information Name:Matthew JohnsonEmail:M.Johnson@rbht.nhs.uk, Study Dr James Darius-Armstrong, Study Study contact information Study Study Name:Joanne BentonEmail:j.benton@rbht.nhs.uk, Study Name: Clare SaundersEmail: c.saunders2@rbht.nhs.uk, Study A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease, Study 3 Adult Intensive Care Unit, Harefield Hospital, Harefield, UK. An open-label study to assess the safety, pharmacokinetics and pharmacodynamics of inhaled PC945 in adult Cystic Fibrosis (CF) patients with persistent pulmonary Aspergillus fumigatus infection, Study contact information A 2x2 factorial randomised single blind open labelled trial to determine the clinical and cost -effectiveness of hypertonic saline (HTS 6%) and carbocysteine versus usual care over 12 months in non-cystic fibrosis bronchiectasis (BE): The Clear study, Study Name: Heather PassmoreEmail: H.Passmore@rbht.nhs.uk. Name:Dr DeepaArachchillageEmail:D.JayakodyArachchillage@rbht.nhs.uk, Principal investigator A multicentre, randomised, double-blind, placebo-controlled study in participants with sarcoidosis-associated pulmonary hypertension (SAPH) to assess the efficacy and safety of oral selexipag, Study contact informationName: Silvia ZagaloEmail: S.Zagalo@rbht.nhs.uk, Principal investigator Name:Rachel SteadEmail:R.Stead@rbht.nhs.uk, Study Real World Clinical Outcomes With Novel Modifier Therapy Combinations in People with CF, Study contact information Name: Nicky MurrayEmail:N.Murray@rbht.nhs.uk, Study He graduated with honors in 2018. Diagnosis and risk stratification in myocarditis using cardiovascular magnetic resonance, detailed molecular markers and gene sequencing - a personalised approach. Studying the airway microenvironment in patients undergoing surgical and bronchoscopic interventions for COPD, Study National Validation and Sensitivity to Change of a scale to measure quality of life in patients with severe asthma. Study contact information Name: Dr Robert SmithEmail: r.smith@rbht.nhs.uk, Study ROR-PH-301 - A StuDy eVAluatiNg the EffiCacy and Safety of RalinEpag To Improve Treatment OUTCOMES in PAH Patients, Study contact informationName: Eleanor MorrisEmail: e.morris@rbht.nhs.uk, Study Name:Dr Samantha IrvingEmail:S.Irving@rbht.nhs.uk, Principal investigator Name: Abigail WatsonEmail: a.watson2@rbht.nhs.uk. Name:Annelise Catelan ZborowskiEmail:A.CatelanZborowski@rbht.nhs.uk. A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a)Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD), Study contact information Name:Sandra ScottEmail:s.scott@rbht.nhs.uk. Autoantibody Predictors of Long-Term Outcomes in Idiopathic Inflammatory Myopathy Associated Interstitial Lung Disease. Name: Camilla GoulsbraEmail: c.goulsbra@rbht.nhs.uk, Study Name:Yousuf SalmasiEmail:M.Salmasi@rbht.nhs.uk, Principal investigator A phase 1, open-label, single-dose, non-randomised study to evaluate pharmacokinetics and pharmacodynamics of edoxaban in pediatric patients, Study contact information Dietary nitrate supplementation to enhance daily physical activity in hypoxic COPD: a randomised controlled trial, Study contact information An observational, retrospective multicentre medical record review to describe the post-authorisation early clinical experience of dupilumab in the treatment of adult severe asthma. Name:Ashraf HussainEmail:A.Hussain@rbht.nhs.uk, Principal investigator Study Name:Dr Tom WongEmail:T.Wong2@rbht.nhs.uk, Study contact information Single-centre validation of finger-prick capillary blood sampling for remote monitoring in chronic lung disease including antifungal therapeutic drug monitoring. Name:Julia KellyEmail:J.Kelly@rbht.nhs.uk, Study Utility of Emphasis-10 in Risk Stratification in Pulmonary Arterial Hypertension. A RandomisEd ControlLed Study of PnEumRx Endobronchial Coil System Versus Standard-of-Care Medical MAnagement in the Treatment of Subjects with Severe Emphysema (ELEVATE) A Postmarket Surveillance Study (PMS). PAciFy Cough: A multicentre, double blind, placebo controlled, crossover trial of morphine sulfate for the treatment of PulmonAry Fibrosis Cough, Study contact informationName:Zhe WuEmail:Z.Wu@rbht.nhs.uk. Metatranscriptomics in Non-Tuberculous Mycobacterial Pulmonary Disease, Study contact information 58 Boulevard Becquart Castelbon, Voiron, Auvergne-Rhne-Alpes 38500 +33 4 76 65 03 39 . Study contact informationName: Dr Colm McCabeEmail:C.McCabe2@rbht.nhs.uk, Study Name:Victoria DoughtyEmail:V.Doughty@rbht.nhs.uk, Study ROR-PH-303 - A StuDy EVAluatiNg the Long-Term EffiCacy and Safety of RalinEpag in Subjects with PAH via an Open-Label EXTENSION, Study Managing abnormal glucose in cystic fibrosis (MAGIC)- the development of a self-management education programme for people with CFRD, Study contact information Open-Label, Baseline-Controlled, Two-Period, Exploratory Study of Safety, Tolerability and Pharmacodynamics of Oral MYK-491 in Stable Ambulatory Patients with Primary Dilated Cardiomyopathy Associated with MYH7 Mutation, Study contact information Study Nasal Allergen Challenge: standardisation as a surrogate for hay fever, Principal investigator Weaning from mechanical ventilation: comparison of open-loop decision support system and routine care in cardiothoracic patients. Two part (double-blind inclisiran versus placebo [Year 1] followed by open-label inclisiran [Year 2]) randomized multicenter study to evaluate safety, tolerability, and efficacy of inclisiran in adolescents (12 to less than 18 years) with heterozygous familial hypercholesterolemia and elevated LDL-cholesterol (ORION-16), Study contact information Prospective Study of Cellular & Clinical Aspects of Moderate to Severe Asthma, Study contact information Name:DeepaArachchillageEmail:D.JayakodyArachchillage@rbht.nhs.uk, Principal investigator Physician and teacher Benjamin Golding was dedicated to providing free medical treatment to the poor. Name:Professor Sejal SaglaniEmail:S.Saglani@rbht.nhs.uk, Study A molecular toolkit for the microbial investigation of severe community acquired pneumonia (S-CAP Study), Study contact information Name: Professor John PepperEmail: j.pepper@rbht.nhs.uk, Study 707 S Garfield Ave Ste 201, Alhambra, CA, 91801 . Name:Maria MartinsEmail:M.Martins@rbht.nhs.uk, Principal investigator
What Vet School Should I Go To Quiz,
Riddles Where The Answer Is Zero,
Half Sibling Dna Test Results,
Shatex Shade Fabric,
Articles D